http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1697832-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_829316dbc94dd5651df97b32aaf2c1de |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-00 |
| filingDate | 1989-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1991-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_582f622a779d302d743cdafd0fbf2f5b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f2bc93a1f1a2dd7a5bb213171a540a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e602d38bd448fd4f1faba61bf7d438fc |
| publicationDate | 1991-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SU-1697832-A1 |
| titleOfInvention | Method for treating bronchial asthma |
| abstract | This invention relates to medicine, in particular to pulmonology. The goal is to achieve and lengthen the remission of the disease in patients with high levels of total immunoglobulin E in the blood. For this, in patients with bronchial asthma with an elevated level of total immunoglobulin E 5, the exacerbation period of the disease exacerbation is performed by thrombocytes. As a result of the use of platelet-phoresis, remission is reached in 85% of patients, which is 5-6 times higher than when plasmapheresis is used. At the same time, its duration is increased by 2 times. 3 tab. |
| priorityDate | 1989-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.